AdaptHealth Corp (NASDAQ: AHCO) has a higher price-to-earnings ratio of 14.95x compared to its average ratio, The 36-month beta value for AHCO is at 1.64. Analysts have varying views on the stock, with 5 analysts rating it as a “buy,” 1 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for AHCO is 86.66M, and currently, shorts hold a 11.22% of that float. The average trading volume for AHCO on June 20, 2025 was 1.51M shares.
AHCO) stock’s latest price update
AdaptHealth Corp (NASDAQ: AHCO)’s stock price has dropped by -0.35 in relation to previous closing price of 8.51. Nevertheless, the company has seen a loss of -3.09% in its stock price over the last five trading days. seekingalpha.com reported 2025-06-02 that AdaptHealth’s national scale and AI-driven efficiencies position it well for value-based contracts, aiming to curb hospital readmissions and improve EBITDA margins. The company faces potential risks from competitive-bidding discounts, unresolved litigation, and execution challenges on the One Adapt ERP migration. Management’s 2025 guidance suggests flat organic revenue and a 21% EBITDA margin, with shares appearing undervalued compared to peers.
AHCO’s Market Performance
AdaptHealth Corp (AHCO) has seen a -3.09% fall in stock performance for the week, with a -5.67% decline in the past month and a -15.37% plunge in the past quarter. The volatility ratio for the week is 1.08%, and the volatility levels for the past 30 days are at 1.91% for AHCO.. The simple moving average for the past 20 days is -4.13% for AHCO’s stock, with a -13.80% simple moving average for the past 200 days.
Analysts’ Opinion of AHCO
Many brokerage firms have already submitted their reports for AHCO stocks, with Jefferies repeating the rating for AHCO by listing it as a “Hold.” The predicted price for AHCO in the upcoming period, according to Jefferies is $8 based on the research report published on January 08, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see AHCO reach a price target of $6.50, previously predicting the price at $9.50. The rating they have provided for AHCO stocks is “Underperform” according to the report published on November 08th, 2023.
Stifel gave a rating of “Hold” to AHCO, setting the target price at $11 in the report published on May 10th of the previous year.
AHCO Trading at -1.97% from the 50-Day Moving Average
After a stumble in the market that brought AHCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.74% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AHCO starting from Rietkerk Shaw, who proposed sale 32,500 shares at the price of $9.70 back on Dec 19 ’24. After this action, Rietkerk Shaw now owns shares of AdaptHealth Corp, valued at $315,250 using the latest closing price.
Clemens Jason A, the Chief Financial Officer of AdaptHealth Corp, sale 35,000 shares at $9.35 during a trade that took place back on Dec 10 ’24, which means that Clemens Jason A is holding 420,719 shares at $327,250 based on the most recent closing price.
Stock Fundamentals for AHCO
Current profitability levels for the company are sitting at:
- 0.08 for the present operating margin
- 0.16 for the gross margin
The net margin for AdaptHealth Corp stands at 0.03. The total capital return value is set at 0.06. Equity return is now at value 5.12, with 1.73 for asset returns.
Based on AdaptHealth Corp (AHCO), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.28. The debt to equity ratio resting at 1.34. The interest coverage ratio of the stock is 1.98.
Currently, EBITDA for the company is 303.37 million with net debt to EBITDA at 3.28. When we switch over and look at the enterprise to sales, we see a ratio of 1.05. The receivables turnover for the company is 7.29for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.29.
Conclusion
In conclusion, AdaptHealth Corp (AHCO) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
